Janet Ho, MD, MPH

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
Address521 Parnassus Avenue, #5311
San Francisco CA 94117
ORCID ORCID Icon0000-0001-6371-1107 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Massachusetts General Hospital, Boston, MA2020Fellowship, Addiction Medicine
    Dana Farber/ Massachusetts General Hospital, Boston, MA2018Fellowship, Palliative Care
    Harvard T. H. Chan School of Public Health, Boston, MAMPH2017
    Harvard Fellowship in General Internal Medicine, Boston, MA2017Fellowship
    Yale Internal Medicine, Primary Care, New Haven, CT2015Residency, Chief Residency
    UC Irvine School of MedicineMD2011
    UC BerkeleyBA/BA2004

    Collapse Overview 
    Collapse Overview
    Dr. Ho is an internist at the University of California, San Francisco who is fellowship trained and board-certified in palliative medicine and addiction medicine. She attends on the Addiction consult service at the Zuckerberg General Hospital, and is the site medical director for inpatient Palliative Care Services at Parnassus. She completed internal medicine training and chief residency at Yale, and fellowships in health services research, palliative care, and addiction medicine at Harvard and Massachusetts General Hospital in Boston, MA. Her clinical and research interests lie at the intersection of serious illness, addiction, pain, chronic cancer pain, harm reduction, and the use of buprenorphine. Dr. Ho is dedicated to improving provider knowledge and confidence in primary palliative care and addiction medicine; improving disparate quality of life and care for patients with serious illness and addiction; promoting harm reduction in palliative care; understanding the role of buprenorphine in palliative care; and challenging stigma against patients who use drugs. She has been an invited speaker at the Harvard Center for Palliative Care courses, the UCSF Division of hospital medicine, the UCSF palliative care fellowship, and at several national conferences. She is a co-leader of the national buprenorphine peer mentorship support group for palliative and hospice providers, a core faculty member of MAPPIT (Managing Addiction and Pain in Palliative Interdisciplinary Teams), and has contributed to several book chapters and publications on addiction and serious illness.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Opioid-prescribing considerations in patients with cancer and substance misuse or substance use disorder: a scoping review protocol. JBI Evid Synth. 2023 04 01; 21(4):812-825. Jones KF, Malinowski J, Paice J, Childers J, Bulls HW, Morrison J, Ho JJ, Alsbrook K, Nugent S, Broglio K, Nickels K, Holbein M, Parajuli J, Merlin JS. PMID: 36404752; PMCID: PMC10260276.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Top Ten Tips Palliative Care Clinicians Should Know About Buprenorphine. J Palliat Med. 2023 01; 26(1):120-130. Neale KJ, Weimer MB, Davis MP, Jones KF, Kullgren JG, Kale SS, Childers J, Broglio K, Merlin JS, Peck S, Francis SY, Bango J, Jones CA, Sager Z, Ho JJ. PMID: 36067137.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    3. The X Waiver to Prescribe Buprenorphine: The Why and How. J Palliat Med. 2022 07; 25(7):1021-1023. Fitzgerald Jones K, Ho JJ, Merlin JS, Weimer M, Sager Z, Kapo J, Childers J. PMID: 35775892.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Sublingual Buprenorphine Initiation: The Traditional Method #441. J Palliat Med. 2022 07; 25(7):1151-1153. Fitzgerald Jones K, Ho J, Sager Z, Broglio K, Wilson Childers J. PMID: 35775890.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Barriers to Buprenorphine Prescribing for Opioid Use Disorder in Hospice and Palliative Care. J Pain Symptom Manage. 2022 08; 64(2):119-127. Janet Ho J, Jones KF, Sager Z, Neale K, Childers JW, Loggers E, Merlin JS. PMID: 35561938.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. De-Stigmatizing the Language of Addiction #429. J Palliat Med. 2022 01; 25(1):155-157. Ho JJ, Jones KF, Sager Z, Wakeman S, Merlin JS. PMID: 34978913; PMCID: PMC9022126.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Adapting Palliative Care Skills to Provide Substance Use Disorder Treatment to Patients With Serious Illness. Am J Hosp Palliat Care. 2022 Jan; 39(1):101-107. Jones KF, Ho JJ, Sager Z, Childers J, Merlin J. PMID: 33685244.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Primary Addiction Medicine Skills for Hospice and Palliative Medicine Physicians: A Modified Delphi Study. J Pain Symptom Manage. 2021 10; 62(4):720-729. Chua IS, Fratt E, Ho JJ, Roldan CS, Gundersen DA, Childers J. PMID: 33677071.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Timeliness of Surveillance Colonoscopy in Underserved Populations: Association with Patient Navigation for Initial Screening Colonoscopy. J Health Care Poor Underserved. 2021; 32(2):712-723. Percac-Lima S, Ashburner JM, Enogieru I, Ho JJ, Mitton J, Richter JM, He W, Whited EC, Atlas SJ. PMID: 34120972.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    10. Opioid and Amphetamine Treatment Trends Among American Indians in the Great Plains. J Addict Med. 2020 Jul/Aug; 14(4):e100-e102. Mitton JA, Jackson S, Ho JJ, Tobey M. PMID: 31725427.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Health Care Utilization and End-of-Life Care Outcomes for Patients With Decompensated Cirrhosis Based on Transplant Candidacy. J Pain Symptom Manage. 2020 03; 59(3):590-598. Ufere NN, Halford JL, Caldwell J, Jang MY, Bhatt S, Donlan J, Ho J, Jackson V, Chung RT, El-Jawahri A. PMID: 31655192; PMCID: PMC7024665.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    12. An International Collaboration for the Training of Medical Chief Residents in Rwanda. Ann Glob Health. 2017 Mar - Apr; 83(2):339-346. Walker T, Dusabejambo V, Ho JJ, Karigire C, Richards B, Sofair AN. PMID: 28619410.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans